Additional IRAEs were present in 3 (10%) patients with PD-1 inhibitor-induced hepatitis, 10 (34%) patients with ipilimumab induced hepatitis and 29 (36%) patients with combination therapy-induced hepatitis. Here, PDCD1 is linked to Hepatitis.